Innovent Biologics（1801.HK）A true leader in innovative bio~drugs

Healthcare and Biotech | 12 August 2024 Innovent Biologics | 1801 HK A true leader in innovative bio-drugs ▶ Strong 2Q24 revenue improves sequentially ▶ Net loss continues to narrow YoY from 2024F ▶ Innovent stays on our medical sector watchlist Strong 50% YoY product revenue growth in 2Q24 and 18% QoQ sequential growth. On 8 Aug 2024, Innovent announced another stand-out quarter, notably total product revenue, which had climbed over 50% YoY to exceed RMB2.0b (2Q23: up 35% YoY), with sequential growth of 18 ...